In this conversation, Dr. Tina Saw, CEO and founder of Oral Genome, discusses her journey from being a general dentist to creating a groundbreaking saliva test that measures oral health biomarkers. The discussion covers the challenges faced in dental practice, the innovative product development process, and the importance of patient engagement in modern dentistry. Dr. Saw emphasizes the need for preventative care and how her product aims to bridge the gap between dental and medical health. The conversation also touches on market trends, insurance coverage, and the future of oral health technology.